•Physician-evaluated measures of psoriasis severity are the primary assessments in psoriasis trials; however, U.S. dermatologists also consider patient-reported outcome (PRO) data when selecting a biologic for moderate-to-severe psoriasis patients PRO evaluations should be integrated into psoriasis clinical trials to obtain the information needed to facilitate treatment decision making
http://bit.ly/2HBhKRj
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου